MedTrace Logo

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

NCT01614652 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 331

Last updated 2017-06-23

No results posted yet for this study

Summary

Treatment of ischemic heart failure.

Conditions

  • Congestive Heart Failure
  • Left Ventricular (LV) Systolic Dysfunction

Interventions

DEVICE

CardioKinetix Parachute Implant and All Appropriate Medical Therapy (AAMT)

CardioKinetix Parachute implant and all appropriate medical therapy

Sponsors & Collaborators

  • CardioKinetix, Inc

    lead INDUSTRY

Principal Investigators

  • William T Abraham, MD · Ohio State University

  • Marco A Costa, MD, PhD · University Hospitals

  • Leslie Saxon, MD · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01614652 on ClinicalTrials.gov